Scientists have developed genetically modified malaria parasites to prime the immune system, offering improved protection ...

By Vijay Kumar Malesu A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, ...

Currently licensed and approved malaria subunit vaccines provide modest, short-lived protection against malaria. Immunization with live-attenuated Plasmodium falciparum malaria parasites is an ...

Edyta Podmokła [Opens in a new window], ...

Until 2002 the treatment of cryptosporidiosis had been far from satisfactory. More than 100 antimicrobial agents have been screened for activity against C. parvum, the majority of which are ...